Vanguard Fiduciary Trust
PCVX icon

Vanguard Fiduciary Trust’s Vaxcyte PCVX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.1M Buy
930,642
+88,369
+10% +$4.8M 0.01% 825
2026
Q1 		$48.9M Buy
+842,273
New +$45.7M 0.01% 796

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Fiduciary Trust's PCVX Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Vaxcyte (PCVX) stake by 10% in Q2 2026, buying an estimated $4.8M and bringing the position to 930,642 shares worth $54.1M. The position accounts for 0.01% of the portfolio, ranked #825.

Vanguard Fiduciary Trust first reported a position in PCVX in Q1 2026 and has held it in 2 quarters since. 330 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Vanguard Fiduciary Trust held 930,642 shares of Vaxcyte worth $54.1M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 88,369 Vaxcyte shares in Q2 2026, an estimated $4.8M.
  • Vaxcyte made up 0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #825 holding.
  • Vanguard Fiduciary Trust first reported a position in Vaxcyte in Q1 2026 and has held it in 2 quarters since.
  • 330 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.